International government guidance recommends patient and public involvement (PPI) to improve the relevance and quality of research. PPI is defined as research being carried out 'with' or 'by' patients and members of the public rather than 'to', 'about' or 'for' them ( ). Patient http://www.invo.org.uk/ involvement is different from collecting data from patients as participants. Ethical considerations also differ. PPI is about patients actively contributing through discussion to decisions about research design, acceptability, relevance, conduct and governance from study conception to dissemination. Occasionally patients lead or do research. The research methods of PPI range from informal discussions to partnership research approaches such as action research, co-production and co-learning. This article discusses how researchers can involve patients when they are applying for research funding and considers some opportunities and pitfalls. It reviews research funder requirements, draws on the literature and our collective experiences as clinicians, patients, academics and members of UK funding panels.
Introduction
Patient and public involvement (PPI) is recommended from the earliest research stages through to dissemination of the findings [1] [2] [3] [4] [5] [6] . In the UK, INVOLVE 3 states that research should be done with and by patients, but what does this mean for researchers and patient partners when starting a study? International resources are available (Box 1) and six UK PPI standards are being tested to see if they work in practice 7 . Table 1 summarises on-line guidance for research applications to international government funding programmes that endorse involving patients and the public. Language varies internationally and is evolving as patients take a more central role in deciding what research is done and how. Box 2 provides some definitions which are derived from the INVOLVE jargon buster 8 and international resources ( Table 1) . PPI includes patients, potential patients, families, carers, patient groups and members of the public who use or have access to health and social care services 3 . We refer to this broad group as 'patients' to distinguish them from clinicians and academics. This is consistent with Canadian guidance, which defines 'patients' as 'an overarching term inclusive of individuals with personal experience of a health issue and informal caregivers, including family and friends' 9 . However, 'patients' may include people who do not describe themselves in this way. People may selfcare for their condition and general public contributions can add value to research questions. Other relevant international terms, for example stakeholder involvement, consumer involvement, knowledge user engagement and patient orientated research are described in Supplementary File 1, Section A.
PPI is put into practice through patients discussing, helping to make decisions and occasionally doing research in order to enhance study relevance, design, conduct and governance. There is no 'one-size-fits-all' approach. Flexibility is required to tailor patient involvement to the topic, research question, methods and resources available. This article describes steps that researchers and patient partners can follow when preparing a research funding application (Box 3). We refer throughout the article to an illustrative example of a researcher who wants to do a study to improve outcomes for patients with migraine, and we provide examples from the literature and authors' experiences.
Steps for how to involve patients and the public when applying for research funding
Understand what patient and public involvement is At the outset, it is important to understand the theory underpinning PPI. In depth reviews and discussion of theory are available 1, 4, [10] [11] [12] [13] and suggest that, depending on the circumstances, PPI will: -ensure that the research questions and outcomes really matter to patients -provide perspectives that complement or challenge those of researchers and clinicians -make research more relevant to the people whom it is designed to benefit -ensure that proposed research will be acceptable to patients so that they will be willing to participate -improve the quality of research -offer lay knowledge that is either independent for the purpose of governance, or specific to the focus of study to enhance its design or conduct -make research more equitable and ethical, particularly when publicly funded -improve dissemination to reach wider lay audiences -increase the likelihood that research will be implemented into everyday practice and impact on patient care
-enable patients to feel that their voice matters.
All of the above could reduce research waste [14] [15] [16] if PPI is put into practice in ways that ensure that research is meaningful, acceptable, ethical and useful.
How does patient involvement differ from patient participation in research?
Patient perspectives can be sought through patient involvement and through patients participating in surveys, interviews or focus groups to provide data for others to analyse, interpret and act on. The authors have observed that in grant applications and study protocols, PPI is often conflated with qualitative research or patient opinion surveys. Collecting data from patients can be important to gain diverse or representative views, but it is different from PPI and both are often needed (Table 2) . Discussion with patients at a workshop can seem similar to collecting data in a focus group, because both involve listening to patients' perspectives, but the context and outcomes from listening differ. PPI means that researchers are in a continuing and reciprocal relationship with patients and make decisions with them about the research. In qualitative research, researchers listen to patients in order to Consumer and community engagement sections are not always mandatory and applicants can decide 'if applicable'.
There is either a form section to complete which asks applicants to enter each community engagement activity separately or instructions to upload either a one or two page document. Fellowship applications require information about community engagement and participation for the previous 5 years or 10 years.
Some forms have 'if applicable' sections which ask applicants to describe: a) how participants will have access to their own results and how the researchers will be accountable to participants for the overall results of the research: b) how they will ensure consumers are involved in the research and how they will communicate results to participants and the community. 
Involving. INVOLVE
3 defines public involvement in research as research being carried out 'with' or 'by' members of the public rather than 'to', 'about' or 'for' them and states that the term 'public' includes:
• Patients, potential patients, carers
• People who use health and social care services
• People from organisations that use services INVOLVE makes a distinction between the 'public' and people who have a professional role in health and social care.
The European Union (EU) website refers to 'citizen Involvement' which includes upstream priority setting, influencing funding decisions to a more direct downstream involvement of citizens and patients in the use and application of medical knowledge and information. It covers both active citizens who engage from a position of agency as well as those unaware of their contribution 25, 'Citizen Science' is used as an EU umbrella term which is envisioned as various forms of public engagement with science as a way to promote responsible research and innovation.
Partnership is when people who get actively involved in research have a relationship that involves mutual respect and have an equal voice. This contrasts to someone who is consulted occasionally. PCORI consider that the principle is demonstrated when time and contributions of patients and stakeholder partners are valued and demonstrated in fair financial compensation, as well as in reasonable and thoughtful requests for time commitment. When PCORI studies include priority populations, the research team is committed to diversity across all project activities and demonstrates cultural competency, including people with disabilities, when appropriate.
Reciprocal Relationships is one of six PCORI engagement principles. They are demonstrated when the roles and decision-making authority of all research partners, including patients, are defined collaboratively and clearly stated.
Collaborating is active, on-going involvement in the research process; however, responsibilities are not equally shared like they are in partnerships. Patients may be co-applicants on a grant application, take part in an advisory group or work with researchers to design, undertake and/or disseminate the results of a research project.
Engaging is a term used in the USA by PCORI and the Canadian Institutes of Health Research. PCORI define engagement as meaningful involvement of patients, carers, citizens, clinicians and other healthcare stakeholders in the topic selection, design, conduct and dissemination of research findings. There are six PCORI patient engagement principles: reciprocal relationships; co-learning, partnerships, transparency, honesty and trust. The UK National Co-ordinating Centre for Public Engagement in Research (https://www.publicengagement. ac.uk/do-it) defines public engagement as: 'the myriad of ways in which the activity and benefits of higher education and research can be shared with the public. Engagement is by definition a two-way process, involving interaction and listening, with the goal of generating mutual benefit'.
Devolving is to place decision making in the hands of patients or communities, for example, a community development approach 26 .
Consulting is gaining feedback from patients and communities through e.g. meetings, on-line fora, workshops. The role is considered to be relatively passive when compared to 'engagement' Action Research brings about improvement or practical change. A group of people who know about a problem work together in a 'partnership' to develop an idea about how it might be resolved. They then go and test this idea. The people who take part in the testing provide feedback on their experiences. It has key tenets Co-production means people who use services, members of the public and professionals working together in a 'partnership' to produce research or service improvement. It is an umbrella term for a concept that means coming together to find a shared solution. 'Co-' can be put before specific research tasks like 'co-design', 'co-build' and 'co-construct'. Co-production 27 covers the whole research process from idea to dissemination of findings in order to change practice.
Co-learning is a term used by PCORI, where the goal is to help patients or other partners to understand research processes. The goal is not to turn patient partners into researchers. PCORI use the term in the context of 'reciprocal relationships', where all research partners including patients learn collaboratively. https://www.pcori.org/sites/default/files/Engagement-Rubric.pdf
Box 3. Overview of how to involve patients in research
A clinician wants to involve patients in a trial of treatment for migraine. Here are steps for involving patients when preparing a research funding application. i. consider which approach will add value and rigour to your research 6. Negotiate appropriate funding to pay patients, reimburse expenses, fund activities and staff time to facilitate patient involvement 7. Consider whether training will be required for the proposed roles and responsibilities 8. Consider whether patients or patient groups will 'do' any research i. do they have appropriate skills?
ii. how will they add value and are there risks?
iii. will they be employed?
iv. who will mentor and provide supervision?
9. Consider the ethical and research governance implications for involving patients in your study 10. Involve patients in writing the grant application 11. Involve patients to plan future reporting and dissemination of your research improve their understanding of a topic. Focus group discussions or qualitative interviews are audio-recorded and transcribed. Researchers collate, analyse and interpret text data from carefully sampled patients to produce valid new knowledge and generate hypotheses. Qualitative and survey research have systematic methodological quality standards. However, the researcher holds the power and patients may express strong views which may not be reported. In any research, the PPI and the data collection to gain wider patient perspectives can be separate, combined or overlap in some study phases, or they can be completely integrated throughout (Figure 1 ). Any combination is possible (Supplementary File 2, Example 1). They are often combined and integrated in equitable partnership research methods like action research, and 'co-' prefixes to research terms, e.g. co-learning and co-production (Box 2).
Action research, co-design, co-learning and co-production Action research historically precedes co-production and gathered momentum in the 1940's as a community-led action in research initiative 19, 20, 30 . The UK National Institute of Health Research (NIHR) who fund research advocate co-production 27 as a method of involving patients meaningfully from start to finish of the research process. Differences in definitions (Box 2) are subtle, vary internationally and researchers may apply the approaches flexibly in practice. 'Partnership approaches' is used in this article as an umbrella term because it acknowledges the changing roles of patients beyond being 'participants' or 'subjects'. Partnership research methods involve patients, clinicians, academics and other relevant stakeholders as equal mutually respected partners in the research team. Being a patient partner implies equal opportunity and equal voice. Equal power in decision-making is sometimes implied, however there are structural and economic power differentials between different types of partner in terms of pay, employment contracts, status and workplace environments. As language is evolving internationally it is more helpful to describe actual patient roles, tasks and responsibilities explicitly rather than use a label for an approach that is open to misinterpretation. For example, co-production 27 may mean consulting patients regularly or patients may actively collect and interpret research data. Terms like 'Participatory Action Research' confuse because the definition of 'participation' in a study means to contribute data, rather than active involvement in research decisions. Partnership research teams decide who has access to participant level data, how to share data securely and how decisions will be made collectively. Partnership approaches can be resource intensive require leadership skills to balance equity of decision-making with a strong scientific rationale. Negotiation skills are required to accommodate different perspectives in order to reach consensus in a timely manner. A starting point for researchers is to find out if patients' priorities already exist for their topic. Many national and international organisations involve patients to identify and publish research priorities specific to a healthcare condition. In the UK, the James Lind Alliance (JLA) specifically identifies and prioritises research questions for funders and there is a register 34, 35 . JLA establish Priority Setting Partnerships which involve collaborations between patients, carers and clinicians. The NIHR funds JLA advisors and the infrastructure, but a Priority Setting Partnership is responsible for its own funding. The JLA has a guidebook which provides step by step processes to identify research uncertainties and prioritise a top 10 list for different conditions 36 . Researchers are advised to evaluate how priorities were established and the rigour of processes, as priorities can change with time and some groups may not have had an opportunity to be involved.
If Decide who and how many patients to involve As with any appointment, selection criteria for patients based on the research plan are useful to inform decisions. Deciding the number of patients to involve in a study requires careful consideration. Two is the minimum number recommended by INVOLVE 3 , however international guidance is less specific. The patient characteristics, skills and numbers will vary according to:
-the study design, e.g. several patients with diverse personal experiences of a health condition may be consulted about which outcomes will be measured in a trial 41 . Co-authors Arthritis Research UK expect patients to be involved in all applications including lab-based early phase research to develop new treatments -the prevalence of the condition, e.g. it may be challenging to identify two or more patients with rare conditions -the relevance and reach of a new intervention, e.g. adverts on Facebook for selected postcodes can identify rural and under-privileged urban perspectives -how much personal tailoring and choice is possible in the design of the research, e.g. two closely involved patients may advise the research team at meetings for a Cochrane Systematic Review, whereas many diverse patient groups may be consulted when prioritising research questions to improve migraine outcomes.
Consider equity of opportunity, unheard perspectives and health inequalities Equity of opportunity for patients to be involved in research underpins UK guidance. The NIHR standards for PPI 7 provide practical examples for how researchers can offer inclusive opportunities and sustain respectful, productive relationships. There is a danger that patient contributors are atypical, as the more confident and financially secure are more likely to volunteer. It can be easier to involve older, white and educated people, which can marginalise other perspectives. Health inequalities and equity are important when making research decisions 42 . Aim to find patients who represent the demographic of those affected by the condition. It can be challenging to access 'typical' members of the target population for the specific research question [42] [43] [44] . See Supplementary File 2, Example 5. An adult or child may be selected to represent their own views 45 or, when the research involves children, vulnerable patients or patients with cognitive impairment, then a guardian, relative or carer may represent the patient's views. A lack of resources can hinder recruiting some patients, such as those from ethnic minorities, the less privileged and less literate. Yet this is important because they tend to experience lower health status and poorer access to services. For these patients it can feel intimidating to meet researchers and attend meetings in a University. Alternative strategies include researchers going out into the community in order to build rapport and trust with patients on their own turf, which can then lead to discussions about research (Supplementary File 2, Example 1) 46, 47 . An outreach model for patient involvement via a link coordinator (professional or lay) can help to access less heard perspectives (Supplementary File 2, Example 5) 48 . A useful guide for getting started and arranging a meeting with patients is available on the INVOLVE website 49 .
A charity partner might help a researcher to plan how patients on low-income or from ethnic minorities can contribute to a research study on migraine. Adverts, social media and attractive visual information in local newspapers and chemist shops may help.
Consider the potential for bias and conflicts of interest PPI in research and political lobbying can co-occur and introduce conflicts of interest with the potential to influence research decisions in ways that have been under-researched 50 . Researchers are advised to consider sources of funding and affiliations of patient contributors, and to re-assess any arising conflicts of interest during their study.
Patients can work with research teams over many years, attend training courses and become a 'PPI methodologist' or expert individual or group. This has advantages and risks. Experienced patients can have an overview of a particular health condition that is invaluable. However, becoming embedded in a research team or an organisation can risk losing the 'eye of the public' 51 . Researchers are advised to consider whether bias due to 'group think' 52 is possible. This is a risk in any established team, for either researchers or patients to become so familiar with the group or clinical area that they lose sight of fresh perspectives. Selecting new untrained patients for a study can highlight researchers' preconceptions and assumptions. However, this also has limitations, as it can be difficult for patients to understand, question and challenge researchers when the language and culture are unfamiliar. Patients who have benefited from or experienced adverse events from a particular treatment can introduce bias. Select patients to balance views, for example patients who have positive and negative outcomes from a new procedure or treatment. It may add rigour to include qualitative or survey research to gain diverse and/or representative patient perspectives.
Throughout all stages of a study, researchers and patients make decisions that need to balance and prioritise evidence, personal experiences and competing values held at the individual, family, organisational, political, cultural and environmental levels. Rigour and quality standards for PPI in research are important to counter critics, as there is still some resistance to implementing PPI 53 .
A researcher is advised to consider conflicts of interest and sources of bias, for example links to industry or private companies. Seek to balance positive and negative patient experiences relevant to the study.
Negotiate and agree an approach, tasks and responsibilities at an early stage Once patients are involved, it is advisable to agree clear boundaries about the scope of the role, specific tasks and responsibilities. Some flexibility is desirable to accommodate unexpected issues that can arise in research and there are grey areas. See Supplementary File 2, Example 6. The approach can be bespoke for each study or for each phase within a study 12, 17, 44, 48, 54 and can vary in the level of patient engagement, responsibility and control. Patients can contribute to three key functions: research decision-making; enhancing understanding of patient experience; and advising how to capture knowledge from other patients. For each function, a question to ask is: which method for involving people will add value and rigour? Example 7 (Supplementary File 2) draws on the work of Gamble and Colleagues who have produced a useful list of tips for patient roles in clinical trials derived from a cohort study of 111 funded trials 28 .
Be realistic about what will be possible to achieve and the resources required 3 . A template for Terms of Reference is available on the INVOLVE website 49 . Terms of Reference acknowledge the importance of mutual respect, practical communication issues and can be reviewed as the research progresses. Researchers may invite patients to propose ground rules for the length of time required to read and respond to emails and comment on documents, for mutual agreement. It is important for researchers to remember that patients may be managing ongoing health conditions which can be unpredictable. Patients value individual constructive and honest feedback about their contributions in order to learn, gain confidence and maintain motivation 7 .
At an early stage a researcher is advised to discuss roles and tasks involved in the migraine study. For example: help to design an appealing patient leaflet, recruit patients, attend project management meetings, interpret findings and present them to lay audiences.
Agree appropriate funding for patient involvement International arrangements for supporting patient involvement in research vary according to the funding opportunity. It is important for researchers to check current guidance for the funding call they are applying to and budgeting guidance is usually available (Table 1) . Negotiate with patients the costs: payment for patient time, any special needs (e.g. childcare, hearing impairment, translation services), training, reimbursement of travel and subsistence expenses. In addition, include costs for staff time to co-ordinate, support, train and facilitate patient involvement. Researchers are advised to spell out to patients the best case and worst case scenarios (e.g. delays to study start and finish), and what contributing to the study would and could involve. Some patients prefer to volunteer, others prefer cash payment or vouchers. Consider patients who are less financially secure. Patients may rely on benefits, part time work or retirement pensions, therefore consider how difficult it is to pay upfront for travel, to scan travel tickets in order to claim research expenses or to have access to computers or printers to access documents for a meeting.
Preparatory PPI activity prior to submitting the grant application can pose a problem for researchers because funding for this is seldom available prior to a grant. Yet this is precisely when patients can have important impact on the study research question, design and plan. In England, the NIHR Research Design Service will provide small amounts of money to cover PPI at the design stage 55 . Some Universities fund generic patient partnership panels (e.g. 56) to work with researchers who are seeking funding and larger charities can often help 57 .
When costing a study about migraine, negotiate sufficient funds to pay for the planned PPI activities, be realistic about the workload and the resources required and consider special needs.
Training for patients involved in research Providing or offering training may or may not be appropriate depending on the patient role and the purpose of training. Training may be desirable in order to undertake highly skilled roles like reviewing grant applications or sitting on independent trial steering committees. In particular, training in the principles of evidence based medicine, with consideration of where and how patient stories fit in evidence hierarchies may be useful. Example 8 (see Supplementary File 2) provides some training programmes that support patient involvement in research. For patients new to a PPI role, support to develop their abilities and confidence to express their views and question researchers may be relevant. Many universities, research funders and charities provide learning and support activities.
There are many PPI tasks where training is not necessary, where a different perspective is what really matters and patient experience of a healthcare condition is the required expertise. For example, when helping to choose important outcomes or advising on patient information or recruitment strategies, 'untrained' patients may make particularly valuable contributions.
Patients doing research
Traditionally, academics with qualifications, experience and recognised research skills collect and analyse data. However, increasingly patients are helping to recruit participants, collect or analyse data and some UK grant application forms ask about this (Supplementary File 1, Section B) . Such questions arguably prime researchers to think that all boxes should be ticked, without considering the implications. Only appropriately trained patients or lay people should undertake research. Shared experiences of a condition can build trust, empathy and a bond which may help to recruit difficult to engage groups, for example children in care 45 . However, attention is required to individual expertise, training requirements, supervision and the scientific rigour necessary to execute high quality research. Patients may do research alongside researchers in partnership research methods 58 and a paradigm of patient-led research is emerging facilitated by social media and digital technologies 59 . INVOLVE has a Patient-Led-Research-Hub to support patients who want to pursue their own research ideas 38 .
In the UK, any researcher accessing study participants who are NHS patients or staff requires a letter of access, sometimes referred to as a 'research passport', obtained from the NHS Research and Development offices (Supplementary File 2, Example 9) 60 . If patients or lay people help to recruit participants to research, gain informed consent or collect, share or analyse data from individual or group discussions, qualitative research or surveys, then they are 'doing research' and there are potential governance implications for the sponsor of the research in terms of employment law, ethics, leave entitlement and indemnity. Researchers should not encourage patients to do research because it requires less resource, or because it obviates the need for relatively costly skilled researchers whilst simultaneously bypassing regulatory hurdles. Rather, researchers and patient partners can decide together whether patient researchers are appropriate and beneficial to specific research projects.
Researchers wanting to study migraine may consider the pros and cons of patients doing aspects of the research and the governance issues.
Working together ethically Consider how to work with patients ethically. PPI can be empowering for individuals and communities, but there are tensions and risks, including exploitation 25 , and the burden and resource implications can be considerable 10 . Some ethical principles for researchers to consider when involving patients in research include:
-avoiding discrimination, undue persuasion, excessive burden or creating a sense of obligation to be involved in the study -the distribution of power in research -valuing patient contributions and fair financial compensation -conflicts of interest, research integrity and respect for intellectual property -the confidentiality of data and protecting anonymity of research participants -advancing science through honest and accurate reporting.
INVOLVE 3 states that UK ethics committee approval is not required when patients advise research teams, prioritise research questions, make choices relating to design, share decisionmaking or disseminate research findings. However, there can be grey areas particularly in relation to defining 'data collection'. NHS or University Ethics committee approval is required in the UK if personal information, i.e. data as defined in the Data Protection Act 61 , is collected, shared and stored for future analysis and reporting. For iterative partnership research approaches like co-production, the current ethics committee processes create many challenges 62 . Researchers can request informed consent from participants to share anonymised data with patient partners, so that they can be involved in analysis and interpretation as members of the study team.
There are international differences in requirements for research ethical and governance approvals, and particular challenges with digital health research 25 which are beyond the remit of this article. New EU General Data Protection Regulation 63 commenced in May 2018, and requires transparency about the source of personal data, the purpose and who data will be shared with.
Audio-recording of PPI meetings in order to write accurate but not verbatim minutes, does not require ethics committee approval. However, it does require at least verbal consent from all present at the start of the meeting and the recording should be destroyed as soon as the minutes are agreed. People should receive forewarning of the intention to audio-record, know the purpose, what will happen to the recording and to the content, and be able to object or withdraw. If audio-recordings are stored for longer than is necessary, transcribed verbatim or if there is an intention to report or publish potentially identifiable quotations or content arising from PPI activities, then ethics committee approval is required. Ethics committees have lay committee members, who consider the ethical issues relating to patient involvement.
A researcher wanting to study migraine should consider the ethical issues when involving patients in the design and conduct of their study. Consider patient burden, equity and power, fair and respectful arrangements, confidentiality and the purpose, processes and consequences of any data collected or stored.
Involve patients in writing a grant application Patients sit on research prioritisation committees and funding panels, alongside clinicians and academics, to decide which research is commissioned and which grants are awarded. See Supplementary File 2, Example 10. Many UK funding panels expect to read convincing and meaningful accounts of how patients have had an impact at key stages: preparatory work to inform the planned research; writing the application form particularly the lay summary; and the proposed PPI activity during the study. Expect to be challenged if PPI appears tokenistic. It is important to consider the trade-offs between specifying a plan for PPI in a research protocol and building in some flexibility for change as the research progresses. This may be challenging in countries where regulatory approvals for amending protocols is time consuming.
Patients can help researchers to write the whole grant application in an engaging, easy to understand language. The lay summary is often one of the first sections in a grant application that funding committee members read to gain an overview of the study. Reviewers like to understand exactly what study participants will experience from start to finish. Describe PPI clearly so that the reader understands who, why, how many, how often, what methods and what impact patients have already had on the grant application and will have in contributing to future research decisions. For example, decisions about recruitment methods, intervention delivery or components, which outcomes will be primary or secondary and how to collect data. It helps to use language precisely and to understand how involving, participating, collaborating, consulting and engaging with patients in research differ (Box 2).
A patient helping to write and edit a grant application can make it clear what will happen to patients who participate and how patients will be involved from study conception to dissemination of findings.
Plan future dissemination of findings Patients can advise on how research might have an impact on health and health care beyond an academic audience. They often have in-depth knowledge of their condition and of on-line sources of information beyond that of academics and clinicians. They can help to write reports, blogs or summaries of findings creatively. See Supplementary File 2, Example 11. Offering participants a lay summary of the research findings is good practice. 'Patients Included Charters' provide accreditation for involving patients in conferences and in journal publications 64 and GRIPP2 PPI reporting guidelines 29,65 are available. Involvement of patients and the public is a critical component in successful implementation of research findings into healthcare, although evidence for best practice is limited 3,66,67 .
The grant application for a study about migraine may propose a public event with a charity to present the results of the study. Researchers and patient partners may give joint talks. Small group discussions with migraine patients can suggest ways to spread the news and change care.

Conclusion
This article provides a starting point for researchers and patient partners who are planning to seek funding for research. There is no current international consensus on best practice or terminology and guidance is evolving across countries and research disciplines. A crucial distinction when gaining patient perspectives is between patient involvement in research and patients participating by providing data in surveys, qualitative interviews or group discussions. The ethical governance implications differ particularly regarding data protection.
Researchers and patient partners can choose a wide range of different approaches to PPI and each study will require consideration of the optimal approach. Rigour is needed because patients' lived experience and persuasive narratives can influence important research decisions and the outcomes are not always predictable. Evidence is needed about how different methods of involving people can improve research decisions, healthcare outcomes and impact. A more collaborative and reciprocal partnership approach with patients has the potential to ensure that research undertaken matters to a wider tranche of society and involves those who stand most to benefit from it.
Key messages
Important questions for researchers about including PPI in their research:
• How can I find people in society (patients, patient groups, carers, the taxpaying public, lay organisations) who can make important contributions to research design, conduct and dissemination?
• How will PPI help me to access the perspectives of those who the research potentially will impact on?
• How can different approaches to involving patients as consultants, collaborators or partners improve the relevance, quality, future implementation and sustainability of research?
• How can patients contribute to three key functions: research decision-making; enhance researchers' understanding of different perspectives; and knowledge capture?
• How can PPI, qualitative research and surveys of patient opinion be optimally combined?
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Current Referee Status: Thank you for the opportunity to review this article -which I think is an important mile stone publication in the business of patient and public involvement in the activity that prepares and contributes to research applications. This is a timely and useful review of the literature and the experiences of the research authors, one day we might look back and realise that investing in this stage of research yields benefits and savings in research down the line. I was interested in the reasons for the authors writing this article and was not surprised to see that it was about the conflation of qualitative research and patient and public involvement in research. This article helpfully, and in a practical way helps to 'de couple' the most pertinent issues in this domain. The use of an illustrative example in migraine research helps to bring the review of evidence and discussion in each section to a useful and practical conclusion for the reader, and could be easily re interpreted for their own research context. It is also a strength in this article that research is considered as both primary studies and research synthesis and reviews, both of which require careful patient and public involvement -in the section Page 3
How does patient involvement differ from patient participation in research? "the context and outcomes from listening (to patients) differ. PPI means that researchers are in a continuing and reciprocal relationship with patients and make decisions with them about the research. In qualitative research, researchers listen to patients in order to improve their understanding of a topic". This is probably the most helpful sentence I have read in a while! The further discussions about the choices of researchers that may or may not include qualitative perspectives in their analysis further underlines that in PPI the power dynamic is different and it is an important difference. Figure 1 is helpful I have a problem with the word iterative -and would suggest a plainer language option especially as the rest of the language used in the diagram is of the non-research variety. Table 2 I struggled with this table maybe because I am not a researcher -I would prefer to see the differences between the two rather than the strengths and limitations of each but can appreciate that for researchers making choices this might be very helpful information and analysis.
Boxes 1 and 2
For an article such as this I think that the are more helpful for readers untangling what is contents of Box 2 meant by PPI in pre funded research and -this information is would put Box 1 as a supplementary file more easily found for a curious researcher and Box 2 really adds value to the article as a whole as authors have collected the (sadly) rather large collection of terminology used in PPI and sought to differentiate it. I like the fact that the authors have stated and used their preferred terminology and articulated the reasons Table 1 I imagine this could be immensely useful to researchers and it is a useful comparison tool but positioning in the middle of the narrative is a shame I think as it breaks up the flow of reading.
Find out what research questions are priorities for patients I think that there is a step before initiating priority setting exercises that encompass PPI -increasingly there are published accounts of priority setting that may or may not include the perspectives of patients and the public. There is also an emerging checklist to support the quality assessment of these accounts and specifically the degree of PPI in them Tong A., Sautenet B., Chapman JR., Appraisal checklist used in a systematic review of priority setting partnerships in health research (Currently being reworked as a priority setting reporting checklist and will be renamed REPRISE Checklist).
Consider equity of opportunity, unheard perspectives and health inequalities
This is a particularly important and pertinent section and offers practical advice and ideas for researchers, especially the use of outreach models that offer more scope for addressing these issues more directly, but may put researchers out of their comfort zones.
Consider the potential for bias and conflicts of interest
This feels an underwritten first paragraph. It feels more important to instigate transparency and declaration of financial and other interests research participants -than the more in-depth for all description of the 'experienced patient?'. Additionally some text about how to manage these conflicts of interests in patients/public may really help readers address this issue.
Agree appropriate funding for patient involvement
There are important considerations here especially around equity of involvement -its good to see these spelled out.
Training for patients involved in research I was very pleased to see this in the text for this section "For patients new to a PPI role, support to develop their abilities and confidence to express their views and question researchers may be relevant." A much under-appreciated aspect of PPI, I would suggest that it doesn't just apply to those new to a role who may find it harder (as am embedded part of the research team) to challenge the research orthodoxy… Also the training needs to be two way -for research teams as well as involved patients and the public.
Key messages Important questions
I like these but I would include a challenging first question to researchers -'Why do they want to do PPI?' I think that there is an important aspect of self-discovery in PPI in research and it helps to understand self/organisational motivations to doing this preparatory work. These reasons may encompass rational or outcome-based reasons (which the current list addresses) but it is also important to understand motivations on a human and relational level. This article gives a comprehensive overview of the involvement of patients, carers and members of the public in health research. It is well written and addresses some important thorny issues in regards to involvement. The article is likely to be useful for researchers new to involvement. Also, as someone who has been facilitating involvement for some time it is very useful to see all this information pulled together. Partly due to the comprehensiveness, I suggest some of the information in boxes and supplements could be cut down. The sheer volume of information might confuse novice readers.
For example, the authors point to the many different and overlapping terms used in this field. For a new author it might be more helpful if the information about all these terms was reduced so that the article focuses on the substantial differences rather than the terms used. I found boxes 1 and 2 quite overwhelming to read through at the beginning of the article. Perhaps it would help if they were supplementary files instead of in-text?
Another example is the definition of 'participating' -I found the introduction to participatory action research here quite confusing because this can be a study design where involvement and participation happen in tandem or are intersected.
Overall, I would have liked to see less of the detailed information on various websites and terms, and more incorporation of the thorny issues, e.g. where research and involvement intersect, and discussion about what we can do about this. It is these aspect of the article that are most interesting, in my view. But the attention to this would depend on the purpose of the article.
Some other comments:
In Box 3, which gives an overview of the involvement process, I would suggest not using the term bias, because this is commonly used for samples. I agree with the point made -and it is important as often ignored in involvement guidelines -but I think it would be better not to use bias and instead say something about whether the topic of the research is contentious amongst different groups of patients (or something to that effect).
Also in Box 3, bullet number 7 mentions roles and responsibilities. I would suggest the agreement of these needs to come much earlier in the process. For example, this could come under point 1 -when the researcher familiarises themselves with involvement. What roles would they like patients, carers or members of the public to have? I really like Tables 1 and 2 In Supplement 2 I find some of the examples lacking in purpose and clarity beyond saying that involvement can happen. I don't find that most of the examples provide new information that isn't available elsewhere in many different formats. However, some examples are very interesting and could merit more space. These are: Example 2 about the cautionary tale -this is a new point that I have not heard before; Example 6 which gives a very interesting example of when qualitative research and involvement overlap (again, would merit more discussion); Example 9 which is very brief but points to how protectionist policies can exclude people from participating (a common reason for not involving children, young people, people with disabilities, the frail elderly and other vulnerable populations) -I don't think this has been considered in-depth by policies intended to increase participation; Example 10 is good on details on how researchers can work collaboratively with patients/carers/members of the public and will be of interest to people looking for new involvement ideas.
You describe patients as primarily fulfilling three functions when they are involved in research: research decision-making, enhancing the patient perspective, how to capture knowledge. I suspect many involved patients/public advisors will object to this as being too limiting. In my own work I have seen at least three additional kinds of input: 1) public advisors helping researchers plan involvement in their research, 2) public advisors helping with dissemination and collaboration strategies (recently a public partner pointed out that the researchers had not asked for a letter of support to a very key national charity which could really help with dissemination), and 3) what I'd call 'hidden or obvious talents'. Examples of the latter are patients drawing on their previous careers or hobbies, or other talents for seeing new aspects of an established research method. A parent carer we work with decided to use VideoScribe to disseminate some research she had initiated, she then presented about this software at a research seminar, and the research programme bought the software as a direct result of hearing her talk about it. In this example the function of the involved parent was to influence the dissemination and communication strategy of a whole programme of work.
I hope these comments are useful. p11 'Decide who and how many patients to involve' -we've moved from people to patients. Needs to be consistent throughout. Also add in something about why you might want to consider having more than one person ie a) public can support each other b) helps redress the power balance in the room and c) the public can not always make a meeting and so, if you have more than one person, it reduced the likelihood that the public voice will be absent at any given time.
p11 Replace the sentence 'Aim to find patients who represent the demogaphics etc' with 'Consider the demographic of those affected etc'. Some readers will take the first sentence to the extreme and it may become a barrier to involving people. I would also suggest losing the sentence 'It can be challenging to access 'typical' members etc' -I'm not sure what is meant by 'typical' here. Need to give some consideration here to the issues of 'representativeness' -when you have only one or two people involved in your research it is unlikely that can be 'the' voice of everyone but they can be 'a' voice. If you want something more representative then surveys etc might be a more appropriate answer.
p11 The authors say that 'the more confident and financially secure are more likely to volunteer'. Need to add in something about researchers have struggled to access certain groups. The sentence 'A lack of resources' -not sure that 'less privileged' is a phrase I would use . Perhaps 'less well off' or something similar? p11 Need to be careful with the sentence 'Yet this is important..' -some ethnic minority groups might be offended that you are asserting that they tend' to experience lower health status' . Perhaps 'some groups tend to experience etc' p12 'Patients can contribute to three key functions etc'. Lose this sentence. I'm not sure that it's true. For example they can also be included in data collection (also applies to the penultimate bullet point in 'key messages' on page 15).
p12 'AT an early stage a researcher is advised to discuss roles and task etc' -I would also add in here behaviours or responsibilities. p13 'Researchers wanting to study migraine etc'. Add on to the end of the sentence 'this entails.' (I read it at first as the patients doing aspects of the governance issues). 
